APOE and neurodegenerative disease: Strategies to modulate SDC function, disrupt lipid raft integrity, or target specific ApoE–SDC interactions could reduce the internalization and aggregation of toxic proteins, potentially slowing or halting the progression of neurodegenerative diseases [14,181].